Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

Regeneron and Sanofi are committed to helping patients in the U.S. who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...

On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results from the open-label Phase 4 ...

Sonis, S. (2000) Defining Mechanisms of Action of Interleukin-11 on the Progression of Radiation-Induced Oral Mucositis in Hamsters. Oral Oncology, 36, 373-381.

Defying Age: The Intriguing Potential of Interleukin-11 Blockers A recent study has shed light on the potential of blocking interleukin-11, a protein involved in inflammation, to extend lifespan by ...

Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R, LASN0 ...

Lack of IL11 (interleukin-11) signaling in mouse model of Marfan Syndrome (mMFS) mice protects against pulmonary fibrosis, emphysema, and elastolysis. A, Representative Masson’s trichrome (MT)-stained ...

More information: Takashi Nishina et al, Interleukin 11 confers resistance to dextran sulfate sodium-induced colitis in mice, iScience (2023). DOI: 10.1016/j.isci.2023.105934 ...

Inhibition of IL-11 signaling also showed a significant anti-fibrotic effect in the lung and skin in animal models of fibrosis. More information on the Phase 1 study (NCT05331300) is available at ...